Month: May 2024

Information on share capital and voting rights – April 2024

Written by Customer Service on May 2, 2024. Posted in Public Companies.

Information on share capital and voting rights April 2024 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations. May 2nd, 2024 Statement made by: Nexans S.A.Registered office : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A)Date Total number of shares Total number of voting rightsTheorical (1) Exercisable (2)April 30th, 2024 43,753,380 43,753,380 43,486,473(1) Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). (2) For information, excluding treasury shares stripped of voting rights, excluding...

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Written by Customer Service on May 2, 2024. Posted in Public Companies.

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), announced today that it will report first quarter 2024 financial results on Thursday, May 9, 2024 before the open of the financial markets. Management will also host a webcast and conference call on May 9, 2024 at 8:30 a.m. ET to discuss the results and provide a corporate update. The live and archived webcast of the call may be accessed on the Virios Therapeutics website under the Investors section: Events and Presentations. The live call can be accessed by dialing 888-506-0062 (domestic) or 973-528-0011 (international) and asking to be connected to the...

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on May 2, 2024. Posted in Public Companies.

New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced the appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (CMO) of the Company, effective May 1, 2024. Dr. Mirza has been an integral part of the Company’s senior team as a consultant since February, 2023 and will now assume a more central role in leading the Company’s development of its expanding clinical pipeline. “Aprea is at a critical point of enriching and expanding its clinical programs. Dr. Mirza has already made significant contributions to Aprea and we...

Invesco Ltd: Form 8.3 – Alpha Financial Markets Consulting PLC_OPD

Written by Customer Service on May 2, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Alpha Financial Markets Consulting plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest...

CORRECTION: LXP Industrial Trust Reports First Quarter 2024 Results

Written by Customer Service on May 2, 2024. Posted in Earnings Releases And Operating Results.

WEST PALM BEACH, Fla., May 02, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by LXP Industrial Trust (NYSE:LXP), please note that the percentage underneath the “Subsequent Events” header was changed from “8%” to “26.9%”. The corrected release follows: LXP Industrial Trust (“LXP”) (NYSE:LXP), a real estate investment trust focused on single-tenant warehouse/distribution real estate investments, today announced results for the quarter ended March 31, 2024. First Quarter 2024 HighlightsRecorded Net Loss attributable to common shareholders of $(1.9) million, or $(0.01) per diluted common share. Generated Adjusted Company Funds From Operations available to all equityholders and unitholders – diluted (“Adjusted Company FFO”) of $48.8 million, or $0.16 per...

Invesco Ltd: Form 8.3 – Anglo American PLC

Written by Customer Service on May 2, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Anglo American PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

InterDigital Announces Financial Results for First Quarter 2024

Written by Customer Service on May 2, 2024. Posted in Earnings Releases And Operating Results.

New license agreements drive 30% increase in YoY revenue and record quarter for Consumer Electronics Company reaffirms full year 2024 guidance WILMINGTON, Del., May 02, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video, and AI technology research and development company, today announced results for the quarter ended March 31, 2024. “InterDigital made significant progress in first quarter towards our 2024 revenue guidance of $620 million to $670 million,” commented Liren Chen, President and CEO, InterDigital. “Revenue was $264 million for the quarter, one of the highest quarters in our history, and included an all-time high for our CE and IoT licensing program. With our landmark consumer electronics agreement with Samsung, we signed agreements with a cumulative value of almost $2.7 billion over the...

Stronghold Announces First Quarter 2024 Operating and Financial Results

Written by Customer Service on May 2, 2024. Posted in Earnings Releases And Operating Results.

Announces Formal Review of Strategic Alternatives NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, the “Company”, or “we”) today announced financial and operational results for the first quarter of 2024 and provided other strategic updates: Recent Financial HighlightsThe Company generated revenues of $27.5 million during the first quarter of 2024, up 27% sequentially and 59% year-over-year. Revenues comprised $26.7 million from cryptocurrency operations, $0.7 million from the sale of energy, and $0.1 million from other activities. First quarter 2024 fixed costs were down 3% sequentially and 11% year-over-year, demonstrating Stronghold’s operating leverage and cost controls. Fixed costs include operations & maintenance expenses and general & administrative expenses,...

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

Written by Customer Service on May 2, 2024. Posted in Earnings Releases And Operating Results.

Reports record revenue of $17.6 million for the first quarter of 2024. Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024. Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023. Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024.WINTER SPRINGS, Fla., May 02, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months ended March 31, 2024. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs...

Itron Announces First Quarter 2024 Financial Results

Written by Customer Service on May 2, 2024. Posted in Earnings Releases And Operating Results.

LIBERTY LAKE, Wash., May 02, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its first quarter ended March 31, 2024. Key results for the quarter include (compared with the first quarter of 2023):Revenue of $603 million, increased 22%; Gross profit of $205 million, increased 31%; GAAP net income attributable to Itron, Inc. of $52 million, increased $64 million; GAAP diluted earnings per share of $1.12, increased $1.38 per share; Non-GAAP diluted EPS of $1.24, increased $0.75 per share; Adjusted EBITDA of $76 million, increased 94%; and Free cash flow of $34 million, increased $40 million.“Itron’s first quarter results reflect strong operational execution within constructive market conditions,” said Tom Deitrich,...

Month: May 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals